Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.64 -2.96%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Protalix BioTherapeutics Gross Profit 2011-2024 | PLX

Annual Gross Profit Protalix BioTherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 43.8 M 24.9 M 4.01 M 801 K 3.63 M 6.11 M 6.08 M 26.3 M 1.44 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
43.8 M 801 K 13 M

Quarterly Gross Profit Protalix BioTherapeutics

2024-Q3 2024-Q2 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- - - - - - - - - - - - - - - - - - - - - - -1.25 M -177 K 1.63 M - 1.46 M 835 K 801 K - 422 K 94 K 156 K - 1.11 M 1.11 M 1.41 M - 1.91 M 1.08 M 3.31 M - 1.77 M 1.75 M 3 M - 3.02 M 22 M 2.41 M - 677 K -4.75 M 5.22 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
22 M -4.75 M 2.04 M